Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Acta Neuropsychiatrica|March 18, 2016
Lofexidine for opiate detoxificationJenny Bearn
International Review of Neurobiology|June 14, 2015
"Addicted to Euphoria": The History, Clinical Presentation, and Management of Party Drug MisuseJenny Bearn, Matthew O'Brien
European Addiction Research|July 2, 2005
Within-patient variability in clinical presentation of gamma-hydroxybutyrate withdrawal: a case reportAnthony Glasper, Michael McDonough, Jenny Bearn
Journal of Substance Abuse Treatment|July 18, 2003
Is opiate detoxification unsafe in pregnancy?Jason Luty, Vasilis Nikolaou, Jenny Bearn
Journal of Substance Abuse Treatment|October 16, 2007
Patterns of adherence to oral methadone: implications for prescribersMichael Haskew, Kim Wolff, John Dunn, et al.
Drug and Alcohol Dependence|July 1, 2004
Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a reviewMichael McDonough, Noel Kennedy, Anthony Glasper, et al.
The American Journal on Addictions|September 25, 2003
The effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trialTracy Beswick, David Best, Jenny Bearn, et al.
Addiction (Abingdon, England)|December 12, 2012
Increased reflection impulsivity in patients with ephedrone-induced ParkinsonismAtbin Djamshidian, Yanosh Sanotsky, Yuriy Matviyenko, et al.
Plos One|March 23, 2013
Harnessing clinical psychiatric data with an electronic assessment tool (OPCRIT+): the utility of symptom dimensionsPhilip James Brittain, Sarah Elizabeth Margaret Lobo, James Rucker, et al.
Pageof 1